Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GB:GSK)
LSE:GSK
GlaxoSmithKline (GSK) Share Price & Analysis
199 Followers
GSK Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range1,276.33p - 1,547.49p
Previous Close1,436p
Volume679.42K
Average Volume (3M)7.69M
Market Cap
£58.75B
Enterprise Value71.36B
Total Cash (Recent Filing)£7.88B
Total Debt (Recent Filing)£20.99B
Price to Earnings (P/E)9.6
Beta0.56
Next Earnings
Jan 31, 2024EPS Estimate
£0.31Last Dividend Ex-Date
Nov 16, 2023Dividend Yield
0.19 (0.01%)Share Statistics
EPS (TTM)1.50
Shares Outstanding4,095,026,002
10 Day Avg. Volume11,123,383
30 Day Avg. Volume7,685,763
Standard Deviation0.05
R-Squared0.29
Alpha0.00638
Financial Highlights & Ratios
Price to Book (P/B)-615.37
Price to Sales (P/S)480.31
Price to Cash Flow (P/CF)703.90
P/FCF Ratio655.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,525.38pPrice Target Upside4.94% Upside
Rating ConsensusHold
Number of Analyst Covering10
GlaxoSmithKline News
Global MarketsGSK Lifts Annual Outlook as Q3 Vaccine Sales Soar
Ownership Overview
1.27% Insiders
10.12% Mutual Funds
10.00% Other Institutional Investors
78.61% Public Companies and Individual Investors
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest share price was 1276.33p and its highest was 1547.49p in the past 12 months.
What is GlaxoSmithKline’s market cap?
Currently, no data Available
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Jan 31, 2024 which is in 57 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on Nov 01, 2023. The company reported 0.504p earnings per share for the quarter, beating the consensus estimate of 0.456p by 0.048p.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Annually dividend of 14p which represents an annual dividend yield of 3.88%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is £0.31.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 4,115,045,400 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of 0.504p in its last earnings report, beating expectations of 0.456p. Following the earnings report the stock price went down -2.36%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Currently, no hedge funds are holding shares in GB:GSK
---
GlaxoSmithKline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
1,525.38p (4.94% Upside)
1,525.38p (4.94% Upside)
Insider Transactions
Bought Shares
Worth £70.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.31%
12-Months-Change
Fundamentals
Return on Equity
54.55%
Trailing 12-Months
Asset Growth
0.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
GlaxoSmithKline
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
---
Top 5 ETFs holding GSK
BMO MSCI AllCntryWrl
$1.55M
Affinity World Leaders Equity ETF
$248.27K
Up to five ETFs with an Outperform Smart Score that hold GSK. The ETFs are listed according to market value of GSK within the ETF
---